6515--Cepheid Infinity Analyzer

The Department of Veterans Affairs, through the Network Contracting Office 23 in Sioux Falls, South Dakota, has awarded a sole-source contract for the procurement of a single Cepheid GeneXpert Infinity 48 Analyzer under Federal Supply Schedule GS-07F-0597T. The acquisition, valued at $278,051.70, was conducted using the FAR 8.405-6 authority for limited sources, justified by the necessity to maintain compatibility with existing laboratory systems, consumables, and operational workflows, as the Cepheid analyzer is proprietary and uniquely interoperable with current infrastructure. No competitive solicitation occurred, and no evaluation factors, technical scoring, or past performance assessments were applied due to the brand-name-only nature of the procurement. The contract was awarded based on the urgency of replacing a degraded unit and the absence of other vendors capable of providing a functionally equivalent system. The award was issued on June 25, 2026, following approval of the brand-name justification on June 2, 2026, and requires posting of the justification on e-Buy as mandated by FAR 8.405-1(e) due to the value exceeding $25,000. The equipment is intended for delivery to the VA Nebraska-Western Iowa Health Care System in Omaha, Nebraska, though the formal place of performance is ambiguously listed as Saint Paul, Minnesota. No detailed packaging, preservation, marking, or bar-coding requirements were specified beyond adherence to brand-name labeling standards, and no inspection criteria beyond conformity to the Cepheid specification were documented. The contracting officer is John Milroy, contacted via email or phone, with no assigned COR/COTR identified. The awardee, Cepheid, located in Sunnyvale, California, holds a Unique Entity ID of W6HQTMWB9Q28 and is classified as other than small, with no socioeconomic certifications or affirmative representations included in the documentation. The acquisition is a firm-fixed-price order under a GSA Schedule, with no option periods, extensions, or additional line items anticipated.